J. Barker

发表

Collection and preservation of cord blood for personal use.

K. Ballen, T. Lane, S. Stewart, 2008, Biology of Blood and Marrow Transplantation.

Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts.

W. Shi, G. Heller, A. Scaradavou, 2011, Blood.

IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia

S. Giralt, H. Pegram, J. Barker, 2014, Leukemia.

Ex Vivo CD34+-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment Response.

J. Goldberg, M. Perales, M. V. D. van den Brink, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantation.

J. Goldberg, M. Perales, S. Devlin, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation

M. Perales, A. Shahrokni, R. Baser, 2020, Bone Marrow Transplantation.

Guidelines for Adult Patient Selection and Conditioning Regimens in Cord Blood Transplant Recipients with Hematologic Malignancies and Aplastic Anemia.

K. Ballen, L. Metheny, A. Rezvani, 2021, Transplantation and cellular therapy.

Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant

E. Robilotti, Cesar J. Figueroa, S. Morjaria, 2018, Science Translational Medicine.

Low-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem cell transplant

J. Goldberg, M. Perales, S. Devlin, 2022, Bone Marrow Transplantation.

Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Relapsed and Refractory Mantle Cell Lymphoma: A Single Center Analysis in the Rituximab Era

A. Zelenetz, M. Perales, S. Devlin, 2015, Bone Marrow Transplantation.

Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis.

S. Devlin, A. Scaradavou, S. Giralt, 2019, Blood advances.

Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies.

G. Papanicolaou, M. Perales, S. Devlin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most.

D. Porter, M. Horowitz, K. Hsu, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Chemotherapy-only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit ATG followed by Allogeneic T-cell Depleted Hematopoietic Stem Cell Transplants for the Treatment of Myeloid Malignancies

M. Perales, K. Hsu, James W. Young, 2018 .

A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies.

M. Perales, M. V. D. van den Brink, K. Hsu, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter's transformation.

A. Zelenetz, M. Perales, S. Devlin, 2021, Blood advances.

[American Society of Blood and Marrow Transplantation (ASBMT) Committee Report: collection and preservation of cord blood for personal use].

K. Ballen, T. Lane, S. Stewart, 2008, Zhongguo shi yan xue ye xue za zhi.

Risk of Relapse (REL) after Umbilical Cord Blood Transplantation (UCBT) in Patients with Acute Leukemia: Marked Reduction in Recipients of Two Units.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2005 .

Paradoxical immune reconstitution inflammatory syndrome associated with disseminated tuberculosis infection in an unrelated donor cord blood transplant recipient

Yeon Joo Lee, G. Papanicolaou, E. Schmidt, 2018, Transplant infectious disease : an official journal of the Transplantation Society.

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.

J Wagner, J. Wagner, C. Eide, 2002, Blood.

HEMATOPOIETIC CELL TRANSPLANTATION : MARROW OR UMBILICAL CORD BLOOD ?

J. Wagner, S. Davies, J. Barker, 2003 .

HEMATOPOIETIC CELL TRANSPLANTATION : MARROW OR UMBILICAL CORD BLOOD ?

J. Wagner, S. Davies, J. Barker, 2003 .

On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia

G. Martinelli, T. Holyoake, J. Lipton, 2008, Leukemia.

ORIGINAL ARTICLE On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia

T. Holyoake, D. DeAngelo, P. Kirschmeier, 2008 .

Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.

J. Wagner, J. Kurtzberg, S. Gerson, 2001, The New England journal of medicine.

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR

M. Perales, J. Pidala, B. Shaw, 2019, Blood.

TRANSPLANTATION The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation

A. Viale, S. Morjaria, Y. Taur, 2014 .

Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34+ selected graft

M. Perales, S. Devlin, James W. Young, 2019, Bone Marrow Transplantation.

Pre-Transplant FDG-PET Scan Lacks Prognostic Value in Chemosensitive B-Cell Non-Hodgkin Lymphoma Patients Undergoing Non-Myeloablative Allogeneic Stem Cell Transplantation.

J. Goldberg, M. Perales, W. Cohen-Levy, 2012 .

An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment.

M. Arcila, G. Heller, M. Moore, 2010, Blood.

Pre-engraftment syndrome after double-unit cord blood transplantation: a distinct syndrome not associated with acute graft-versus-host disease.

G. Heller, James W. Young, A. Scaradavou, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units.

J. Wagner, Jeffrey S. Miller, M. MacMillan, 2009, Blood.

Imbalanced immune response and dysregulation of neural functions underline fatal opportunistic encephalitis caused by astrovirus

K. Wollenberg, A. Nath, M. Weller, 2022, bioRxiv.

Umbilical-cord blood transplantation for the treatment of cancer

J. Wagner, J. Barker, 2003, Nature Reviews Cancer.

Who Should Get Cord Blood Transplants

J. Barker, 2007 .

Umbilical cord blood transplantation: current state of the art

J. Wagner, J. Barker, 2002, Current opinion in oncology.

Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: A comparative clinical analysis

J. Wagner, M. MacMillan, B. Hirsch, 2007, American journal of hematology.

Umbilical cord blood transplantation: current practice and future innovations.

J. Wagner, J. Barker, 2003, Critical reviews in oncology/hematology.

Combining the disease risk index and hematopoietic cell transplant co‐morbidity index provides a comprehensive prognostic model for CD34+‐selected allogeneic transplantation

M. Perales, James W. Young, J. Peled, 2020, Advances in cell and gene therapy.

Long-term prognosis for 1-year relapse-free survivors of CD34 cell–selected allogeneic hematopoietic stem cell transplantation: a landmark analysis

M. Perales, M. V. D. van den Brink, S. Devlin, 2017, Bone Marrow Transplantation.

Ex Vivo T Cell-Depleted Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Myeloid Leukemia in First and Second Remission: Long-Term Disease-Free Survival with a Significantly Reduced Risk of Graft-versus-Host Disease.

M. Perales, James W. Young, S. Giralt, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High progression-free survival after intermediate intensity double unit cord blood transplantation in adults.

M. Perales, S. Devlin, K. Hsu, 2020, Blood advances.

Cord blood transplants: one, two or more units?

S. Avery, J. Barker, 2010, Current opinion in hematology.

C. Sauter, J. Barker, 2008, Current opinion in hematology.

Engraftment Kinetics after Transplantation of Double Unit Cord Blood Grafts Combined with Haplo-identical CD34+ Cells without Anti-thymocyte Globulin

M. Arcila, M. Perales, S. Devlin, 2020, Leukemia.

CD34+ cell content of 126 341 cord blood units in the US inventory: implications for transplantation and banking.

J. Kurtzberg, E. Shpall, J. Kempenich, 2019, Blood advances.

Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice.

S. Devlin, A. Scaradavou, S. Giralt, 2014, Blood.

Dominant unit CD 34 1 cell dose predicts engraftment after double-unit cord blood transplantation and is in fl uenced by bank practice

S. Devlin, A. Scaradavou, S. Giralt, 2014 .

New approaches in alternative donor transplantation.

H. Heslop, M. F. Fernandez Vina, J. Barker, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities.

M. V. D. van den Brink, G. Heller, James W. Young, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants.

Anajane G. Smith, S. Spellman, C. Hurley, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

graft-versus-leukemia effect in recipients of 2 units Relapse risk after umbilical cord blood transplantation: enhanced

J. Wagner, Jeffrey S. Miller, M. MacMillan, 2013 .

Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.

G. Papanicolaou, S. Seo, N. Cohen, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Human Cytomegalovirus Infection Promotes Expansion of a Functionally Superior Cytoplasmic CD3+ NK Cell Subset with a Bcl11b-Regulated T Cell Signature

Joseph C. Sun, K. Hsu, T. Mertens, 2021, The Journal of Immunology.

Low dose Unfractionated Heparin Prophylaxis is a Safe Strategy for the Prevention of Hepatic Sinusoidal Obstruction Syndrome After Myeloablative Adult Allogenic Stem Cell Transplant

J. Goldberg, M. Perales, S. Devlin, 2022, Bone Marrow Transplantation.

Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units

J. Wagner, D. Weisdorf, J. Miller, 2009, Bone Marrow Transplantation.

Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2003, Blood.

High Disease-Free Survival and Enhanced Protection Against Relapse after Double-Unit Cord Blood Transplantation (DCB-T) When Compared to Unrelated Donor Transplantation (URD-T) in Patients with Acute Leukemia, MDS and CML

J. Goldberg, M. Perales, S. Devlin, 2014 .

Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match.

J. Goldberg, M. Perales, R. Jenq, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Phase 2 Study of F-652, a Novel Tissue-Targeted Recombinant Human Interleukin-22 (IL-22) Dimer, for Treatment of Newly Diagnosed Acute Gvhd of the Lower GI Tract

M. V. D. van den Brink, J. Shia, A. Alousi, 2020 .

Safety and Immunogenicity of the 13-Valent Protein-Conjugated Pneumococcal Vaccine(PCV13) Following Related and Unrelated Hematopoietic Stem Cell Transplantation (HCT)

M. Perales, S. Giralt, T. Small, 2011 .

Has umbilical cord blood transplantation for AML become mainstream?

K. Ballen, J. Barker, 2013, Current opinion in hematology.

Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplant

J. Teruya-Feldstein, J. Goldberg, M. Perales, 2012, Leukemia & lymphoma.

Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia

E. Papaemmanuil, O. Abdel-Wahab, R. Levine, 2022, American journal of hematology.

Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies

M. Perales, A. Shahrokni, S. Devlin, 2019, Bone Marrow Transplantation.

The Hematopoietic Cell Transplant-Co-Morbidity Index (HCT-CI) Predicts Outcomes After T Cell Depleted (TCD) Allogeneic HCT For AML and MDS

J. Goldberg, M. Perales, S. Devlin, 2013 .

A. Scaradavou, V. Rocha, J. Barker, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant Recipients.

M. Perales, S. Devlin, J. Nelson, 2020, Journal of palliative medicine.

Racial disparities in access to alternative donor allografts persist in the era of “donors for all”

M. Perales, James W. Young, A. Scaradavou, 2021, Blood advances.

Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation.

N. E. Babady, Yeon Joo Lee, G. Papanicolaou, 2020, The Journal of clinical investigation.

Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source.

J. Wagner, R. Hough, M. MacMillan, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Safety and Efficacy of Intermittent Intravenous Administration of High-Dose Micafungin.

G. Papanicolaou, M. Perales, N. Cohen, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A single center, open-label trial of isavuconazole prophylaxis against invasive fungal infection in patients undergoing allogeneic hematopoietic cell transplant (HCT).

Yeon Joo Lee, G. Papanicolaou, S. Seo, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation

J. Goldberg, M. Perales, G. Hobbs, 2016, Bone Marrow Transplantation.

T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease.

J. Goldberg, M. Perales, R. Jenq, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation.

J. Wagner, J. Tolar, D. Weisdorf, 2006, Blood.

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.

J. Wagner, M. Horowitz, R. Gale, 2004, The New England journal of medicine.

Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients.

J. Wagner, J. Kurtzberg, M. Trigg, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.

J. Wagner, S. Davies, D. Weisdorf, 2001, Blood.

Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: a 12-year single institution study.

G. Papanicolaou, S. Seo, S. Giralt, 2014, The Journal of infection.

Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant

J. Goldberg, M. Perales, S. Devlin, 2015, Leukemia & lymphoma.

Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin.

G. Papanicolaou, M. Perales, M. V. D. van den Brink, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Safety and Efficacy of Intermittent Intravenous Administration of High-Dose Micafungin.

G. Papanicolaou, M. Perales, N. Cohen, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy.

Todd E DeFor, Daniel J Weisdorf, John E Wagner, 2005, Blood.

Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow.

Todd E DeFor, Daniel J Weisdorf, John E Wagner, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Extended-duration letermovir prophylaxis for cytomegalovirus infection after cord blood transplantation in adults

G. Papanicolaou, S. Seo, M. Perales, 2022, Blood advances.

Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplant

G. Papanicolaou, M. Perales, S. Devlin, 2015, Leukemia & lymphoma.

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2007, Blood.

Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.

G. Papanicolaou, M. Perales, S. Devlin, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation.

A. Viale, S. Morjaria, Y. Taur, 2014, Blood.

How I treat: the selection and acquisition of unrelated cord blood grafts.

A. Scaradavou, J. Barker, C. Byam, 2011, Blood.

A "no-wash" albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions.

G. Heller, A. Scaradavou, V. L. La Russa, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

E. Robilotti, Cesar J. Figueroa, Yeon Joo Lee, 2017, The Journal of infectious diseases.

Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation.

Daigo Hashimoto, Robert R Jenq, Amy Bush, 2020, The New England journal of medicine.

Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies.

A. Scaradavou, C. Stevens, J. Barker, 2010, Blood.

Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease.

Y. Taur, E. Pamer, J. Goldberg, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation.

M. Perales, R. Jenq, M. V. D. van den Brink, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Relationship of mycophenolic acid exposure to clinical outcome after hematopoietic cell transplantation

D. Weisdorf, R. Remmel, P. Jacobson, 2005, Clinical pharmacology and therapeutics.

A Limited Sampling Model for Estimation of Total and Unbound Mycophenolic Acid (MPA) Area Under the Curve (AUC) in Hematopoietic Cell Transplantation (HCT)

D. Weisdorf, P. Jacobson, J. Ng, 2006, Therapeutic drug monitoring.

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation.

J. Teruya-Feldstein, C. Hedvat, G. Heller, 2012, Blood.

Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation.

R. Khanin, Y. Taur, E. Pamer, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Umbilical Cord Blood (UCB) transplantation: an alternative to the use of unrelated volunteer donors?

Juliet N Barker, J. Barker, 2007, Hematology. American Society of Hematology. Education Program.

Cord blood units with low CD34+ cell viability have a low probability of engraftment after double unit transplantation.

James W. Young, A. Scaradavou, N. Kernan, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Guidelines for Cord Blood Unit Selection.

J. Wagner, E. Shpall, A. Scaradavou, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cell Dose and Immunogenetic Considerations in Cord Blood Transplantation

J. Barker, I. Politikos, 2017 .

Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2008, Blood.

Evaluation of Cord Blood Total Nucleated and CD34+ Cell Content, Cell Dose and 8-allele HLA-Match by Patient Ancestry.

S. Devlin, A. Scaradavou, E. Davis, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplant.

J. Teruya-Feldstein, M. Arcila, M. Perales, 2020, The Journal of clinical investigation.

Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor Selection.

M. Perales, S. Devlin, A. Scaradavou, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy.

J. Klein, M. Horowitz, F. Locatelli, 2014, Blood.

The Dose-Match Interaction in Umbilical Cord Blood (UCB) Transplantation: An Analysis of the Impact of Cell Dose and HLA-Match on the Disease-Free Survival (DFS) of 989 Patients Transplanted with Single Units for Hematologic Malignancy.

P. Rubinstein, A. Scaradavou, C. Stevens, 2007 .

A. Rausen, J. Barker, C. Sauter, 2010, Bone Marrow Transplantation.

Chronic graft-versus-host disease (cGVHD) following unrelated donor hematopoietic stem cell transplantation (HSCT): higher response rate in recipients of unrelated donor (URD) umbilical cord blood (UCB).

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autoimmune hemolysis and immune thrombocytopenic purpura after cord blood transplantation may be life-threatening and warrants early therapy with rituximab

M. Perales, S. Devlin, A. Scaradavou, 2016, Bone Marrow Transplantation.

Guidelines for the Prevention and Management of Graft-versus-Host Disease after Cord Blood Transplantation.

M. MacMillan, A. Alousi, M. Horwitz, 2021, Transplantation and cellular therapy.

Response: the controversy of red blood cell–replete cord blood units

A. Scaradavou, J. Barker, 2011 .

Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation.

M. Perales, R. Jenq, M. V. D. van den Brink, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.

J. Wagner, J. Kurtzberg, E. Shpall, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Searching for unrelated donor hematopoietic stem cells

J. Wagner, S. Davies, D. Weisdorf, 2002 .

Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience

G. Papanicolaou, S. Seo, M. Perales, 2019, Transplant infectious disease : an official journal of the Transplantation Society.

Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients

G. Papanicolaou, S. Seo, M. Perales, 2019, Bone Marrow Transplantation.

High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia.

M. Perales, M. V. D. van den Brink, S. Devlin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical Peripheral Blood CD34+ Cells (HaploCD34+) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection, and Frequent Pre-Engraftment Syndrome

M. Perales, James W. Young, A. Scaradavou, 2015 .

Cord Blood: an Alternative Stem Cell Source or a New Standard?

J. Barker, 2009 .

Donor–recipient allele-level HLA matching of unrelated cord blood units reveals high degrees of mismatch and alters graft selection

S. Devlin, A. Scaradavou, S. Giralt, 2014, Bone Marrow Transplantation.

Results of a prospective multicentre myeloablative double‐unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia

S. Devine, B. Logan, T. Kindwall‐Keller, 2015, British journal of haematology.

Guidelines for Cord Blood Unit Thaw and Infusion.

J. Kurtzberg, A. Scaradavou, S. Avecilla, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

"No wash" albumin-dextran dilution for double-unit cord blood transplantation is safe with high rates of sustained donor engraftment.

S. Devlin, A. Scaradavou, S. Giralt, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Letermovir Prophylaxis Demonstrates High Efficacy in Adult Cytomegalovirus (CMV) Seropositive Cord Blood Transplant (CBT) Recipients: A Comparison with Pre-Letermovir Era CBT Controls

G. Papanicolaou, S. Seo, M. Perales, 2019, Biology of Blood and Marrow Transplantation.

Clinical Research : Alternative Donors Intensi fi ed Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation

M. Perales, R. Jenq, S. Devlin, 2022 .

Analysis of Cyclosporine A Levels Supports New Dosing Guidelines in Adult Double-Unit Cord Blood Transplant Recipients to Optimize Immunosuppression Early Post-Transplant.

J. Barker, D. Ponce, A. Lin, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cord blood T cells are "completely different".

A. Hanash, J. Barker, 2015, Blood.

Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia.

J. Wagner, E. Shpall, L. Isola, 2013, Blood.

Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.

Jeffrey S. Miller, D. Weisdorf, M. Arora, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

In Vivo T Cell Depletion with Myeloablative Regimens on Outcomes after Cord Blood Transplantation for Acute Lymphoblastic Leukemia in Children.

J. Wagner, M. Perales, R. Sparapani, 2015, Biology of Blood and Marrow Transplantation.

Guidelines for Infection Prophylaxis, Monitoring and Therapy in Cord Blood Transplantation.

C. Brunstein, A. Olson, J. Barker, 2021, Transplantation and cellular therapy.

Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin.

M. Perales, M. V. D. van den Brink, S. Giralt, 2020, Blood advances.

Incidence and Risk Factors for Acute and Chronic Kidney Injury After Adult Cord Blood Transplantation.

T. Muthukumar, S. Devlin, E. Jaimes, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation.

J. Goldberg, M. Perales, R. Jenq, 2015, Blood.

Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival.

J. Wagner, Priya Kumar, D. Weisdorf, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors.

J. Wagner, D. Weisdorf, D J Weisdorf, 2001, The New England journal of medicine.

CD34+ Viability Is a Critical Determinant of the Engraftment Potential of Umbilical Cord Blood (UCB) in Double Unit Transplantation.

A. Scaradavou, N. Kernan, N. Collins, 2007 .

The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia

M. Perales, M. Territo, D. Weisdorf, 2017, Haematologica.

The use of back-up units to enhance the safety of unrelated donor cord blood transplantation.

G. Heller, A. Scaradavou, S. Giralt, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Double-Unit Cord Blood (CB) Transplantation Combined with Haplo-Identical CD34+ Cells Results in 100% CB Engraftment with Enhanced Myeloid Recovery

J. Goldberg, M. Perales, S. Devlin, 2014 .

M. Perales, F. Appelbaum, J. Pidala, 2014, Haematologica.

Double-Unit Cord Blood (CB) Transplantation Combined With Haplo-Identical CD34+ Cell-Selected PBSC Results In 100% CB Engraftment With Enhanced Myeloid Recovery

J. Goldberg, M. Perales, S. Devlin, 2013 .

Analysis of 402 Cord Blood Units to Assess Factors Influencing Infused Viable CD34+ Cell Dose: The Critical Determinant of Engraftment

A. Scaradavou, R. Meagher, C. Stevens, 2013 .

Sustained donor engraftment in recipients of double-unit cord blood transplantation is possible despite donor-specific human leukoctye antigen antibodies.

S. Devlin, A. Scaradavou, S. Hsu, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sustained Donor Engraftment in Recipients of Double-Unit Cord Blood Transplantation is Possible Despite Donor-Specific HLA- Antibodies

S. Devlin, A. Scaradavou, Jonathan Barone, 2014 .

Determinants of survival after human leucocyte antigen‐matched unrelated donor bone marrow transplantation in adults

Jeffrey S. Miller, S. Davies, D. Weisdorf, 2002, British journal of haematology.

bone marrow : results of a matched-pair analysis matched unrelated donor − comparable to that of human leukocyte antigen Survival after transplantation of unrelated donor umbilical cord blood

J. Wagner, S. Davies, D. Weisdorf, 2001 .

Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation.

James W. Young, A. Scaradavou, A. Hanash, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Urgent Time to Allogeneic Hematopoietic Cell Transplantation: A National Survey of Transplant Physicians and Unrelated Donor Search Coordinators Facilitated by the Histocompatibility Advisory Group to the National Marrow Donor Program.

M. Perales, J. Pidala, B. Shaw, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

6: Risk of Relapse after Umbilical Cord Blood Transplantation in Patients with Acute Leukemia: Marked Reduction in Recipients of Two Units

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2006 .

Analysis of the CD34+ cell to total nucleated cell content ratio of 619 transplanted and back-up cord blood units

A. Scaradavou, E. Davis, J. Barker, 2020, Bone Marrow Transplantation.

Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantation

M. Voss, C. Hedvat, A. Scaradavou, 2012, Bone Marrow Transplantation.

Regarding "Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study".

M. Perales, J. Pidala, M. Maiers, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes.

M. Perales, M. Doubrovin, R. O'reilly, 2010, Blood.

Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation

M. Perales, S. Devlin, S. Giralt, 2022, Leukemia & lymphoma.

A phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with B cell lymphoid malignancies: favorably durable event-free survival in chemosensitive patients.

A. Zelenetz, J. Goldberg, M. Perales, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Human cytomegalovirus expands a CD8+ T cell population with loss of BCL11B expression and gain of NK cell identity

Joseph C. Sun, K. Hsu, R. Brentjens, 2021, Science Immunology.

A Phase I Dose Escalation Trial of Donor T Cells Sensitized with Pentadecapeptides of the CMV-pp65 Protein for the Treatment of CMV Infections Following Allogeneic Hematopoietic Stem Cell Transplants.

G. Papanicolaou, M. Perales, James W. Young, 2009 .

Molecular Predictors and Effectiveness of Measurable Residual Disease (MRD) Eradication with Chemotherapy and Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

E. Papaemmanuil, O. Abdel-Wahab, M. Arcila, 2020 .

Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP53 alterations

M. Perales, P. Hamlin, S. Giralt, 2018, British journal of haematology.

Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves

E. Robilotti, M. Kamboj, M. Perales, 2021, Transplantation and Cellular Therapy.

Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial

J. Wagner, D. Douek, M. MacMillan, 2007, Bone Marrow Transplantation.

Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34+ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation.

M. Perales, M. V. D. van den Brink, S. Devlin, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A phase 2 study of Interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract.

M. Perales, M. V. D. van den Brink, S. Devlin, 2022, Blood.

Adenovirus viremia and disease: comparison of T cell-depleted and conventional hematopoietic stem cell transplantation recipients from a single institution.

Yeon Joo Lee, G. Papanicolaou, Junting Zheng, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell Transplantation.

S. Morjaria, Y. Taur, E. Pamer, 2016, American journal of respiratory and critical care medicine.

Analysis of 608 Umbilical Cord Blood (UCB) Transplants: HLA-Match Is a Critical Determinant of Transplant-Related Mortality (TRM) in the Post-Engraftment Period Even in the Absence of Acute Graft-vs-Host Disease (aGVHD).

P. Rubinstein, A. Scaradavou, C. Stevens, 2005 .

enhance engraftment in adults with hematologic malignancy Transplantation of two partially HLA-matched umbilical cord blood units to

J. Wagner, C. Verfaillie, D. Weisdorf, 2009 .

Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma.

Jeffrey S. Miller, M. MacMillan, D. Weisdorf, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program.

B. Sandmaier, D. Porter, K. Ballen, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Efficacy of high‐dose therapy and hematopoietic stem cell transplantation for mantle cell lymphoma

Jeffrey S. Miller, D. Weisdorf, M. Arora, 2006, American journal of hematology.

The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT

M. Perales, M. V. D. van den Brink, A. Nagler, 2021, Blood advances.

Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adults.

M. Perales, A. Shahrokni, S. Giralt, 2019, Blood advances.

An optimized search prognosis tool to predict 8/8 HLA-allele matched unrelated donor procurement.

A. Scaradavou, J. Flynn, E. Davis, 2023, Transplantation and cellular therapy.

Validation of an Algorithm to Predict the Likelihood of an 8/8 HLA-Matched Unrelated Donor at Search Initiation.

S. Devlin, A. Scaradavou, S. Giralt, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Analysis of Disparities in Time to Allogeneic Transplantation in Adults with Acute Myelogenous Leukemia.

M. Perales, S. Devlin, James W. Young, 2022, Blood advances.

Inaccuracies in assignment of patient race and ethnicity: implications for unrelated donor searches and health care delivery

A. Scaradavou, E. Davis, W. Fingrut, 2022, Blood advances.

Fourth complete remission with immunosuppression withdrawal and irinotecan after both autologous and allogeneic transplants for diffuse large B cell lymphoma

James W. Young, A. Noy, J. Barker, 2009, Leukemia & lymphoma.

Safety of voriconazole and sirolimus coadministration after allogeneic hematopoietic SCT

J. Goldberg, M. Perales, S. Devlin, 2015, Bone Marrow Transplantation.

KIR and HLA genotypes have no identifiable role in single unit dominance following double unit umbilical cord blood transplantation

K. Hsu, G. Heller, J. Chou, 2014, Bone Marrow Transplantation.

Fludarabine Pharmacokinetics in Nonmyeloablative Hematopoietic Cell Transplantation (HCT): Association with Engraftment and Neurotoxicty.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2005 .

Disease Progression is Main Barrier to Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in Patients with Newly Diagnosed and Relapsed Acute Leukemia

M. Perales, M. Tallman, S. Giralt, 2018 .

Graft-Vs-Graft Immune Interaction Is the Likely Mechanism of Absolute Unit Dominance in Double Unit Cord Blood (DCB) Transplantation Using Patient DCB Grafts: An in Vivo but Not in Vitro Phenomenon

M. Arcila, M. Moore, L. Eldjerou, 2008 .

Analysis of the CD34+ Cell Content of 126, 341 Cord Blood (CB) Units in the NMDP be the Match Inventory: Implications for CB Transplantation and Public Banking

J. Kurtzberg, E. Shpall, J. Kempenich, 2018 .

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in the Treatment of Acute Lymphocytic Leukemia (ALL) in 126 Adults: Impact of Donor Source on Leukemia Free Survival (LFS).

J. Wagner, Priya Kumar, Jeffrey S. Miller, 2005 .

Disease-Free Survival After Cord Blood (CB) Transplantation Is Not Different to That After Related or Unrelated Donor Transplantation in Patients with Hematologic Malignancies.

M. Perales, R. Jenq, K. Hsu, 2009 .

Umbilical cord blood transplantation: current state of the art

J. Wagner, J. Barker, 2002 .

Evaluation of Initial Telomere Length and Changes after Transplantation in Adult Double-Unit Cord Blood Transplant Recipients.

A. Zehir, M. Moore, Beth Ashbridge, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Evaluation of Initial Telomere Length and Changes Post-Transplant in Adult Double Unit Cord Blood Transplantation Recipients

A. Zehir, Beth Ashbridge, J. Barker, 2015 .

HEMATOPOIETIC CELL TRANSPLANTATION : MARROW OR UMBILICAL CORD BLOOD ?

J. Wagner, S. Davies, J. Barker, 2003 .

Allogeneic Transplantation for Chronic Myelomonocytic Leukemia (CMML) Is Associated with High Disease-Free Survival Even in the Setting of High-Risk Disease

W. Shi, S. Devlin, S. Giralt, 2014 .

Outcomes of adult T-Cell leukemia/lymphoma with allogeneic stem cell transplantation: single-institution experience

H. Schoder, M. Perales, S. Horwitz, 2021, Leukemia & lymphoma.

An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment.

M. Arcila, G. Heller, M. Moore, 2010, Blood.

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation.

J. Teruya-Feldstein, C. Hedvat, G. Heller, 2012, Blood.

Pathogenesis and outcome of VA1 astrovirus infection in the human brain are defined by disruption of neural functions and imbalanced host immune responses

K. Wollenberg, A. Nath, M. Weller, 2023, PLoS pathogens.

Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Relapsed and Refractory Mantle Cell Lymphoma: A Single Center Analysis in the Rituximab Era

A. Zelenetz, M. Perales, S. Devlin, 2015, Bone Marrow Transplantation.

Reduced Intensity Compared to Non-myeloablative Conditioning in Patients with Non-Hodgkin Lymphoma undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

M. Perales, S. Devlin, A. Jakubowski, 2023, Transplantation and cellular therapy.

Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant

E. Robilotti, Cesar J. Figueroa, S. Morjaria, 2018, Science Translational Medicine.

M. Perales, M. V. D. van den Brink, S. Devlin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

9: Analysis of 608 Umbilical Cord Blood (UCB) Transplants: HLA-Match is a Critical Determinant of Transplant-Related Mortality (TRM) in the Post-Engraftment Period Even in the Absence of Acute Graft-vs-Host Disease (aGVHD)

P. Rubinstein, A. Scaradavou, C. Stevens, 2006 .